2,328
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers

, , , , , , , , , & show all
Article: 2220849 | Received 09 Apr 2023, Accepted 24 Apr 2023, Published online: 08 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Diego Orsini, Paolo Iacovelli, Pasquale Frascione & Alessia Pacifico. (2023) Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report. Journal of Dermatological Treatment 34:1.
Read now
Sotirios G. Tsiogkas, Maria G. Grammatikopoulou, Katerina-Maria Kontouli, Ioanna Minopoulou, Dimitrios D. Goulis, Efterpi Zafiriou, Dimitrios P. Bogdanos & Aikaterini Patsatsi. (2023) Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis. Expert Review of Clinical Immunology 19:12, pages 1485-1498.
Read now

Articles from other publishers (3)

D. Orsini, P. Frascione, C. Assorgi, A. Pacifico, I. Sperduti, L. Gargiulo, L. Ibba, M. Valenti, A. Costanzo & A. Narcisi. (2023) Risankizumab for the treatment of genital psoriasis: A 1‐year, real‐world experience. Journal of the European Academy of Dermatology and Venereology.
Crossref
Marco Cintoni, Marta Palombaro, Fabio Stefano Maramao, Pauline Raoul, Gabriele Egidi, Elena Leonardi, Luca Bianchi, Elena Campione, Emanuele Rinninella, Antonio Gasbarrini & Maria Cristina Mele. (2023) Metabolic Disorders and Psoriasis: Exploring the Role of Nutritional Interventions. Nutrients 15:18, pages 3876.
Crossref
L. Gargiulo, L. Ibba, P. Malagoli, F. Amoruso, G. Argenziano, A. Balato, F. Bardazzi, M. Burlando, C. G. Carrera, G. Damiani, P. Dapavo, V. Dini, G. Fabbrocini, C. Franchi, F. M. Gaiani, G. Girolomoni, C. Guarneri, C. Lasagni, F. Loconsole, A. V. Marzano, M. Maurelli, M. Megna, D. Orsini, F. Sampogna, M. Travaglini, M. Valenti, A. Costanzo & A. Narcisi. (2023) A risankizumab super responder profile identified by long‐term real‐life observation‐ IL PSO ( ITALIAN LANDSCAPE PSORIASIS ) . Journal of the European Academy of Dermatology and Venereology.
Crossref